ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis
19/03/2026 | 4min
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.
West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding
05/03/2026 | 5min
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.
EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy
19/02/2026 | 4min
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy
19/02/2026 | 4min
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
05/02/2026 | 4min
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.